用双能量CT预测状动脉静脉静脉复缩:一项多中心研究
Weiming Hu1,2, Guihan Lin1, Weiyue Chen1
1Zhejiang Key Laboratory of Imaging and Interventional Medicine, Zhejiang Engineering Research Center of Interventional Medicine Engineering and Biotechnology, Key Laboratory of Precision Medicine of Lishui City, The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, China.
European radiology
|November 6, 2025
概括
结合双能计算断层扫描 (DECT) 参数和临床因素的新型诺莫格拉姆模型准确地预测了 carotid 动脉支架 (CAS) 后的 stent 静止 (ISR) 风险. 这种工具有助于个性化治疗策略,以获得更好的患者结果.
科学领域:
- 血管外科 血管外科
- 放射学 放射学是一门学科.
- 医疗成像医学成像
背景情况:
- 在 carotid 动脉支架 (CAS) 后的 stent 静止 (ISR) 构成重大风险,需要准确的预测工具.
- 目前评估ISR风险的方法往往是主观的,准确性有限.
研究的目的:
- 评估双能计算断层扫描 (DECT) 参数在预测后CAS.ISR的临床价值.
- 开发和验证一个包含DECT参数的nomogram模型,用于增强ISR风险预测.
主要方法:
- 对205名患者的回顾性分析,这些患者接受了手术前DECT扫描的CAS.
- 两个放射科医生对DECT参数和斑块特征进行独立评估.
- 开发和验证使用AUC和校准的临床,DECT和名谱模型,使用DCA进行临床实用.
主要成果:
- 斑块长度,脂肪分数,正常化度和有效原子数被确定为独立的ISR预测因素.
- 诺米图模型实现了高预测准确性 (AUC 0.931培训,0.872验证),超过了临床和DECT模型.
- 校准曲线和决策曲线分析证实了名图的卓越性能和临床实用性.
结论:
- 开发的诺米图,整合了DECT参数和临床因素,为预测CAS后ISR风险提供了一种可靠的非侵入性方法.
- 该工具支持个性化治疗规划和早期干预,可能改善患者的治疗结果并降低中风风险.
相关概念视频
01:28Imaging Studies for Cardiovascular System V: CT
268
Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
268
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
377
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
377